|
|
|
Insider
Information: |
Arbuckle Stuart A |
Relationship: |
Director |
City: |
Cambridge, |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
62,795 |
|
Indirect Shares
|
140 |
|
|
Direct
Value |
$22,243,455 |
|
|
Indirect Value
|
$62,654 |
|
|
Total
Shares |
62,935 |
|
|
Total
Value |
$22,306,109 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2024-05-15 |
49,691 |
2024-05-15 |
140 |
Premium* |
|
Dare Bioscience Inc |
DARE |
Director |
2017-01-03 |
13,104 |
2016-10-03 |
0 |
Premium* |
|
Immunogen Inc |
IMGN |
Director |
2024-02-12 |
0 |
2023-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
192 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2022-02-10 |
4 |
D |
$237.74 |
$722,730 |
D/D |
(3,040) |
76,438 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2022-02-17 |
4 |
D |
$232.51 |
$959,336 |
D/D |
(4,126) |
72,312 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2022-02-24 |
4 |
D |
$227.86 |
$1,651,074 |
D/D |
(7,246) |
65,066 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2023-02-10 |
4 |
D |
$294.33 |
$992,481 |
D/D |
(3,372) |
92,880 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2023-02-13 |
4 |
D |
$298.26 |
$1,786,577 |
D/D |
(5,990) |
86,890 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2023-02-17 |
4 |
D |
$292.85 |
$1,317,239 |
D/D |
(4,498) |
71,107 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2023-02-24 |
4 |
D |
$289.12 |
$1,362,912 |
D/D |
(4,714) |
61,590 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2024-02-09 |
4 |
D |
$422.74 |
$1,343,045 |
D/D |
(3,177) |
80,013 |
0 |
- |
|
IMGN |
Immunogen Inc |
Director |
|
2024-02-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,381) |
0 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2024-02-16 |
4 |
D |
$424.01 |
$1,907,621 |
D/D |
(4,499) |
71,219 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2024-02-20 |
4 |
D |
$420.58 |
$1,418,616 |
D/D |
(3,373) |
67,846 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2024-02-23 |
4 |
D |
$431.79 |
$2,035,458 |
D/D |
(4,714) |
54,725 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-04-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
150 |
138,120 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2016-05-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
150 |
115,774 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2014-09-19 |
4 |
OE |
$45.11 |
$2,601,285 |
D/D |
52,500 |
110,202 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2014-11-05 |
4 |
OE |
$45.11 |
$191,718 |
D/D |
4,250 |
121,514 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-04-27 |
4 |
OE |
$45.11 |
$3,000,404 |
D/D |
50,875 |
188,995 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-08-05 |
4 |
OE |
$45.11 |
$1,168,141 |
D/D |
19,828 |
147,343 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-09-04 |
4 |
OE |
$53.74 |
$487,046 |
D/D |
9,063 |
136,578 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-11-05 |
4 |
OE |
$45.11 |
$301,889 |
D/D |
6,264 |
111,012 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-11-16 |
4 |
OE |
$77.31 |
$282,182 |
D/D |
3,650 |
108,541 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-12-04 |
4 |
OE |
$53.74 |
$243,496 |
D/D |
4,531 |
108,995 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-04-28 |
4 |
OE |
$45.11 |
$1,277,515 |
D/D |
28,320 |
159,567 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-06-01 |
4 |
OE |
$53.74 |
$730,542 |
D/D |
13,594 |
145,061 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-06-02 |
4 |
OE |
$77.31 |
$4,628,505 |
D/D |
57,375 |
188,842 |
0 |
- |
|
192 Records found
|
|
Page 6 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|